Yatharth Hospital shares leapt 6% to ₹1,067, topping their 52‑week low and driving the stock to a 55% year‑to‑date rally.
The board approved a preferential allotment of up to ₹3,150 crore – comprising 1.30 crore common shares at ₹985.17 each (₹1,283.33 crore) and 1.89 crore convertible warrants at the same price (₹1,866.67 crore).
Advent International will receive a 24.9% fully diluted stake, while the Tyagi family retains 55.8% of the shares; the issuance also bumps the authorised capital from ₹115 crore to ₹150 crore.
The move comes as the healthcare sector sees several mega‑fundraises; for example, Care Hospitals raised $650 million last year. Yatharth’s valuation now sits at ₹1,067 per share, above the sector median of ₹920, signalling premium investor appetite.
Shareholders will vote at the extraordinary general meeting on October 15, and the company has indicated that it will push forward with the planned expansion of 5,000 beds by 2029 – a move that could lift the EPS margin beyond the current 12%.